First Commonwealth Financial (FCF) is expected to report results on Tuesday
First Commonwealth Financial (NYSE: FCF) is expected to release its quarterly results after market close on Tuesday, July 27. Analysts expect First Commonwealth Financial to post earnings of $ 0.30 per share for the quarter. People who wish to register for the corporate earnings conference call can do so by using this link.
First Commonwealth Financial (NYSE: FCF) last released its quarterly results on Tuesday, April 27. The bank reported EPS of $ 0.41 for the quarter, beating analyst consensus estimates of $ 0.29 by $ 0.12. First Commonwealth Financial posted a return on equity of 10.56% and a net margin of 27.23%. The company posted revenue of $ 96.80 million in the quarter, compared to analysts’ expectations of $ 95.98 million. In the same quarter of the previous year, the company posted earnings per share of $ 0.05. The company’s quarterly revenue grew 11.3% year-over-year. On average, analysts expect First Commonwealth Financial to post EPS of $ 1 for the current fiscal year and EPS of $ 1 for the next fiscal year.
NYSE: FCF opened at $ 13.01 on Tuesday. The company has a leverage ratio of 0.21, a current ratio of 0.90, and a quick ratio of 0.90. First Commonwealth Financial has a 12-month low of $ 7.14 and a 12-month high of $ 15.69. The stock’s 50-day simple moving average is $ 14.54. The stock has a market cap of $ 1.25 billion, a PE ratio of 11.62 and a beta of 1.14.
The company also recently announced a quarterly dividend, which was paid on Friday, May 21. Investors registered on Friday, May 7 received a dividend of $ 0.115 per share. The ex-dividend date of this dividend was Thursday, May 6. This represents an annualized dividend of $ 0.46 and a dividend yield of 3.54%. This is a boost from First Commonwealth Financial’s previous quarterly dividend of $ 0.11. First Commonwealth Financial’s dividend payout ratio (DPR) is currently 56.79%.
Several analysts recently published reports on the company. Stephens assumed coverage of First Commonwealth Financial in a research report on Tuesday, March 30. They set an “overweight” rating and a target price of $ 16.50 for the company. Zacks investment research upgraded First Commonwealth Financial from a “custody” rating to a “strong buy” rating and set a target price of $ 17.00 for the company in a research report released on Friday, April 30. Five analysts assigned a conservation rating to the stock, two assigned a buy rating and one assigned a high buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $ 12.42.
In other news from First Commonwealth Financial, Executive Vice President Norman J. Montgomery sold 20,000 shares of the company in a transaction that took place on Tuesday, June 8. The stock was sold at an average price of $ 15.22, for a total trade of $ 304,400.00. After the transaction closes, the Executive Vice President now owns 56,137 shares of the company, valued at approximately $ 854,405.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed via this link. Company insiders own 1.68% of the company’s shares.
About First Commonwealth Financial
First Commonwealth Financial Corporation, a financial holding company, provides a variety of personal and business banking services to individuals and small and medium-sized businesses in the United States. Its consumer services include personal chequing accounts, interest-bearing chequing accounts, health savings and savings accounts, insured money market accounts, debit cards, investment certificates, interest rate certificates of deposit. fixed and variable, mortgages, secured and unsecured installment loans, construction and real estate loans, safes, credit cards, lines of credit with overdraft protection, IRA accounts, and automated teller machines (ABMs) ), as well as Internet, mobile and telephone banking services.
Recommended Story: How to Execute an Ex-Dividend Business Strategy?
This instant news alert was powered by storytelling technology and MarketBeat financial data to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured article: What does a market performance rating mean?
7 health actions serving innovation in 2021
We all knew that traditional health services were disrupted in 2020. The patient-doctor relationship has gone virtual. During the first months of the pandemic, many people in need of elective surgeries simply did not have this option available to them. And even local pharmacies have taken on a new role in e-commerce as curbside pickup or home delivery of prescription drugs has become the norm.
Unsurprisingly, healthcare stocks took a rough ride last year. Overall, the sector was down 11%, well below the S&P 500 which climbed more than 15%.
However, the market is always looking to the future with a particular eye on innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in the advanced testing phase for drugs that can deliver groundbreaking results for conditions that continue to plague our world.
This is the object of this presentation. We have identified 7 healthcare actions that offer innovative ideas that will help achieve better patient outcomes. And in some cases, it will completely revolutionize medicine. These are also the stocks that analysts watch.
Consult the “7 healthcare stocks for innovation in 2021”.